Cargando…
Targeting EIF4F complex in non-small cell lung cancer cells
Non-small cell lung cancer (NSCLC) accounts for about 85–90% of lung cancer cases, which represents the leading cause of cancer-related death in the world. The majority of lung cancer patients doesn't respond well to conventional chemo-/radio-therapeutic regimens and have a poor prognosis. The...
Autores principales: | Dai, Lu, Lin, Zhen, Cao, Yueyu, Chen, Yihan, Xu, Zengguang, Qin, Zhiqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5589694/ https://www.ncbi.nlm.nih.gov/pubmed/28903455 http://dx.doi.org/10.18632/oncotarget.18413 |
Ejemplares similares
-
Elevation of EIF4G1 promotes non‐small cell lung cancer progression by activating mTOR signalling
por: Lu, Ying, et al.
Publicado: (2021) -
Functional role of eukaryotic translation initiation factor 4 gamma 1 (EIF4G1) in NSCLC
por: Cao, Yueyu, et al.
Publicado: (2016) -
Role of EIF4G1 network in non‐small cell lung cancers (NSCLC) cell survival and disease progression
por: Del Valle, Luis, et al.
Publicado: (2021) -
Targeting xCT, a cystine-glutamate transporter induces apoptosis and tumor regression for KSHV/HIV-associated lymphoma
por: Dai, Lu, et al.
Publicado: (2014) -
Genomic analysis of xCT-mediated regulatory network: identification of novel targets against AIDS-associated lymphoma
por: Dai, Lu, et al.
Publicado: (2015)